Clinical Trials Directory

Trials / Conditions / Opioid-Induced Constipation (OIC)

Opioid-Induced Constipation (OIC)

9 registered clinical trials studyying Opioid-Induced Constipation (OIC) — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingNaldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Pa
NCT07231796
Professor Monique A. H. Steegers—
RecruitingProphylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study
NCT07038551
International University of Health and WelfarePhase 4
RecruitingSafety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids
NCT05588323
ShionogiPhase 1 / Phase 2
CompletedA 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patien
NCT01395524
AstraZenecaPhase 3
CompletedA Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Co
NCT01333540
Theravance BiopharmaPhase 2
CompletedAssessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
NCT01336205
AstraZenecaPhase 3
CompletedAssessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
NCT01323790
AstraZenecaPhase 3
CompletedAssessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
NCT01309841
AstraZenecaPhase 3
CompletedA Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients Wi
NCT00600119
AstraZenecaPhase 2